| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Mar | May » | |||||
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||
April 5th, 2012 tmccoy
by: Michael Werner, Esq. The HeartMate II Left Ventricular Assist System (“HM LVAS”) is used as a bridge to transplantation in heart transplant candidates at risk of imminent death from non-reversible left ventricular failure. The HM LVAS is also used in patients with specific end-stage left-ventricular failure who have received optimal medical therapy for at [...]
April 5th, 2012 tmccoy
by: Jonathan Macri, Esq. Individuals suffering from multiple sclerosis who thought they had found a revolutionary breakthrough drug to aid in their fight against the disease may have to think again. Gilenya, billed as “the first once-daily pill for reducing the number of relapses in people with relapsing forms of MS,” has recently been studied [...]
April 5th, 2012 tmccoy
by: Stephanie Herschaft, Esq. A recent study published in Cancer Research, reported that use of Depo-Provera (depo-medroxyprogesterone acetate, or DPMA), an injectable progestin-only birth control for over a year or more doubles the risk of birth control in young women. This contraception uses the same kind of progestin found in the hormone-therapy regimen used in [...]
